Maharashtra Government Suspends Four FDA Officials Amid Tobacco Raid Controversy
Four senior officers of the FDA in Maharashtra have been suspended over procedural irregularities in tobacco raids, with inquiries launched against 21 others.
Four FDA officers, including a Joint Commissioner, suspended for irregularities in tobacco enforcement actions.
Investigations focus on procedural lapses during raids at two tobacco manufacturing firms in Thane and Pune.
A total of 21 officials are under inquiry as the FDA reviews compliance with legal provisions.
The Maharashtra government has taken decisive action by suspending four senior officers from the Food and Drug Administration (FDA) due to allegations of serious procedural irregularities during enforcement actions against two tobacco manufacturing companies. This decision comes in the wake of regulatory raids conducted at High Street Impex LLP in Thane and SOEX India Pvt Ltd in Pune's Maval taluka. The suspended officials include Joint Commissioner (Food) Digambar Bhogawade, Assistant Commissioner (Food) Yaduraj Dahatonde, and Food Safety Officers Ashok Ilager and C R Swami, with Dahatonde being based in Nagpur while the others served in Pune.
The disciplinary measures are rooted in investigations into significant procedural lapses that occurred during inspections at the two firms. In the case of High Street Impex, officials reportedly initiated enforcement actions under food safety laws despite the packaging clearly stating that the products were not for edible use and were intended solely for hookah smoking. The FDA is now examining the legal grounds for applying food safety regulations to non-edible products that carry explicit warnings against consumption.
In a separate incident, a raid conducted by an FDA special flying squad at SOEX India resulted in the seizure of over 5,48,000 kilograms of banned tobacco products, valued at approximately ₹31.67 crore. However, questions have arisen regarding the jurisdiction of the flying squad to conduct such inspections and seizures in the Maval area, raising concerns about compliance with mandatory legal provisions during the enforcement actions.
The punitive actions taken against the FDA officials have sparked considerable debate within the agency, with some questioning the fairness of the suspensions. An assistant commissioner has claimed that the disciplinary measures were misdirected, suggesting that a food safety officer involved in the product sampling was not suspended while others were penalized. Furthermore, the identities of the 21 officials under inquiry have not been disclosed, leading to calls for transparency in the ongoing investigations.
As the FDA embarks on a comprehensive review of all raids, seizures, and related legal proceedings involving the two tobacco firms, the outcomes of these inquiries will determine the next steps. The agency aims to identify administrative lapses and assign individual responsibility, with further punitive actions contingent on the findings of the investigations.
